For generations, periodontitis has resisted treatment not because medicine lacked weapons, but because the bacterium at its heart learned to hide inside the very cells meant to be protected. A research team at Peking University has now demonstrated that simvastatin — a cholesterol drug already trusted by millions — can close that hiding place, reducing the antibiotic burden needed to control infection while helping damaged tissue rebuild itself. The finding, published in July 2026, points toward a philosophy of treatment that works with the body's defenses rather than simply escalating the che